MUMBAI, India, March 28 -- Intellectual Property India has published a patent application (202517023718 A) filed by Jiangsu Hengrui Pharmaceuticals Co. Ltd.; and Shanghai Hengrui Pharmaceutical Co. Ltd., Jiangsu, China, on March 17, for 'anti-ilt4 antibody and pharmaceutical use thereof.'
Inventor(s) include Ye, Xin; Sun, Le; Jin, Xinsheng; and Ying, Hua.
The application for the patent was published on March 28, under issue no. 13/2025.
According to the abstract released by the Intellectual Property India: "The present invention provides an anti-ILT4 antibody and pharmaceutical use thereof."
The patent application was internationally filed on Sept. 08, 2023, under International application No.PCT/CN2023/117653.
Disclaimer: Curated by H...